Network-based transfer of pan-cancer immunotherapy responses to guide breast cancer prognosis

Abstract Breast cancer prognosis is complicated by tumor heterogeneity. Traditional methods focus on cancer-specific gene signatures, but cross-cancer strategies that provide deeper insights into tumor homogeneity are rarely used. Immunotherapy, particularly immune checkpoint inhibitors, results fro...

Full description

Saved in:
Bibliographic Details
Main Authors: Xiaobao Ding, Lin Zhang, Ming Fan, Lihua Li
Format: Article
Language:English
Published: Nature Portfolio 2025-01-01
Series:npj Systems Biology and Applications
Online Access:https://doi.org/10.1038/s41540-024-00486-7
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1841544521179987968
author Xiaobao Ding
Lin Zhang
Ming Fan
Lihua Li
author_facet Xiaobao Ding
Lin Zhang
Ming Fan
Lihua Li
author_sort Xiaobao Ding
collection DOAJ
description Abstract Breast cancer prognosis is complicated by tumor heterogeneity. Traditional methods focus on cancer-specific gene signatures, but cross-cancer strategies that provide deeper insights into tumor homogeneity are rarely used. Immunotherapy, particularly immune checkpoint inhibitors, results from variable responses across cancers, offering valuable prognostic insights. We introduced a network-based transfer (NBT) of pan-cancer immunotherapy responses to enhance breast cancer prognosis using node embedding and heat diffusion algorithms, identifying gene signatures netNE and netHD. Our results showed that netHD and netNE outperformed seven established breast cancer signatures in prognostic metrics, with netHD excelling. All nine gene signatures were grouped into three clusters, with netHD and netNE enriching the immune-related interferon-gamma pathway. Stratifying TCGA patients into two groups based on netHD revealed significant immunological differences and variations in 20 of 50 cancer hallmarks, emphasizing immune-related markers. This approach leverages pan-cancer insights to enhance breast cancer prognosis, facilitating insight transfer and improving tumor homogeneity understanding. Abstract graph of network-based insights translating pan-cancer immunotherapy responses to breast cancer prognosis. This abstract graph illustrates the conceptual framework for transferring immunotherapy response insights from pan-cancer studies to breast cancer prognosis. It highlights the integration of PPI networks to bridge genetic data and clinical phenotypes. The network-based method facilitates the identification of prognostic gene signatures in breast cancer by leveraging immunotherapy response information, providing a novel perspective on tumor homogeneity and its implications for clinical outcomes.
format Article
id doaj-art-7c9a2e82f300452aa3a2e58feba096c2
institution Kabale University
issn 2056-7189
language English
publishDate 2025-01-01
publisher Nature Portfolio
record_format Article
series npj Systems Biology and Applications
spelling doaj-art-7c9a2e82f300452aa3a2e58feba096c22025-01-12T12:28:51ZengNature Portfolionpj Systems Biology and Applications2056-71892025-01-0111111210.1038/s41540-024-00486-7Network-based transfer of pan-cancer immunotherapy responses to guide breast cancer prognosisXiaobao Ding0Lin Zhang1Ming Fan2Lihua Li3Institute of Biomedical Engineering and Instrumentation, Hangzhou Dianzi UniversityInstitute of Biomedical Engineering and Instrumentation, Hangzhou Dianzi UniversityInstitute of Biomedical Engineering and Instrumentation, Hangzhou Dianzi UniversityInstitute of Biomedical Engineering and Instrumentation, Hangzhou Dianzi UniversityAbstract Breast cancer prognosis is complicated by tumor heterogeneity. Traditional methods focus on cancer-specific gene signatures, but cross-cancer strategies that provide deeper insights into tumor homogeneity are rarely used. Immunotherapy, particularly immune checkpoint inhibitors, results from variable responses across cancers, offering valuable prognostic insights. We introduced a network-based transfer (NBT) of pan-cancer immunotherapy responses to enhance breast cancer prognosis using node embedding and heat diffusion algorithms, identifying gene signatures netNE and netHD. Our results showed that netHD and netNE outperformed seven established breast cancer signatures in prognostic metrics, with netHD excelling. All nine gene signatures were grouped into three clusters, with netHD and netNE enriching the immune-related interferon-gamma pathway. Stratifying TCGA patients into two groups based on netHD revealed significant immunological differences and variations in 20 of 50 cancer hallmarks, emphasizing immune-related markers. This approach leverages pan-cancer insights to enhance breast cancer prognosis, facilitating insight transfer and improving tumor homogeneity understanding. Abstract graph of network-based insights translating pan-cancer immunotherapy responses to breast cancer prognosis. This abstract graph illustrates the conceptual framework for transferring immunotherapy response insights from pan-cancer studies to breast cancer prognosis. It highlights the integration of PPI networks to bridge genetic data and clinical phenotypes. The network-based method facilitates the identification of prognostic gene signatures in breast cancer by leveraging immunotherapy response information, providing a novel perspective on tumor homogeneity and its implications for clinical outcomes.https://doi.org/10.1038/s41540-024-00486-7
spellingShingle Xiaobao Ding
Lin Zhang
Ming Fan
Lihua Li
Network-based transfer of pan-cancer immunotherapy responses to guide breast cancer prognosis
npj Systems Biology and Applications
title Network-based transfer of pan-cancer immunotherapy responses to guide breast cancer prognosis
title_full Network-based transfer of pan-cancer immunotherapy responses to guide breast cancer prognosis
title_fullStr Network-based transfer of pan-cancer immunotherapy responses to guide breast cancer prognosis
title_full_unstemmed Network-based transfer of pan-cancer immunotherapy responses to guide breast cancer prognosis
title_short Network-based transfer of pan-cancer immunotherapy responses to guide breast cancer prognosis
title_sort network based transfer of pan cancer immunotherapy responses to guide breast cancer prognosis
url https://doi.org/10.1038/s41540-024-00486-7
work_keys_str_mv AT xiaobaoding networkbasedtransferofpancancerimmunotherapyresponsestoguidebreastcancerprognosis
AT linzhang networkbasedtransferofpancancerimmunotherapyresponsestoguidebreastcancerprognosis
AT mingfan networkbasedtransferofpancancerimmunotherapyresponsestoguidebreastcancerprognosis
AT lihuali networkbasedtransferofpancancerimmunotherapyresponsestoguidebreastcancerprognosis